These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28283002)

  • 21. The costs of treating long-term diabetic complications in a developing country: a study from India.
    Kumpatla S; Kothandan H; Tharkar S; Viswanathan V
    J Assoc Physicians India; 2013 Feb; 61(2):102-9. PubMed ID: 24471248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The health care costs of diabetic peripheral neuropathy in the US.
    Gordois A; Scuffham P; Shearer A; Oglesby A; Tobian JA
    Diabetes Care; 2003 Jun; 26(6):1790-5. PubMed ID: 12766111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of managing complications resulting from type 2 diabetes mellitus in Canada.
    O'Brien JA; Patrick AR; Caro JJ
    BMC Health Serv Res; 2003 Mar; 3(1):7. PubMed ID: 12659641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China].
    Wang AH; Xu ZR; Ji LN;
    Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):224-7. PubMed ID: 22490790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A model to estimate cost-savings in diabetic foot ulcer prevention efforts.
    Barshes NR; Saedi S; Wrobel J; Kougias P; Kundakcioglu OE; Armstrong DG
    J Diabetes Complications; 2017 Apr; 31(4):700-707. PubMed ID: 28153676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of diabetes on costs before and after major lower extremity amputations in Germany.
    Hoffmann F; Claessen H; Morbach S; Waldeyer R; Glaeske G; Icks A
    J Diabetes Complications; 2013; 27(5):467-72. PubMed ID: 23746556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The costs of diabetic foot: the economic case for the limb salvage team.
    Driver VR; Fabbi M; Lavery LA; Gibbons G
    J Am Podiatr Med Assoc; 2010; 100(5):335-41. PubMed ID: 20847346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost burden to diabetic patients with foot complications--a study from southern India.
    Shobhana R; Rao PR; Lavanya A; Vijay V; Ramachandran A
    J Assoc Physicians India; 2000 Dec; 48(12):1147-50. PubMed ID: 11280217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting.
    Apelqvist J; Ragnarson-Tennvall G; Larsson J; Persson U
    Foot Ankle Int; 1995 Jul; 16(7):388-94. PubMed ID: 7550950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers.
    Hicks CW; Selvarajah S; Mathioudakis N; Perler BA; Freischlag JA; Black JH; Abularrage CJ
    J Vasc Surg; 2014 Nov; 60(5):1247-1254.e2. PubMed ID: 24939079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost of diabetic foot in France, Spain, Italy, Germany and United Kingdom: A systematic review.
    Tchero H; Kangambega P; Lin L; Mukisi-Mukaza M; Brunet-Houdard S; Briatte C; Retali GR; Rusch E
    Ann Endocrinol (Paris); 2018 Apr; 79(2):67-74. PubMed ID: 29544659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the most effective way to reduce incidence of amputation in the diabetic foot?
    Apelqvist J; Larsson J
    Diabetes Metab Res Rev; 2000; 16 Suppl 1():S75-83. PubMed ID: 11054894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The economic impact of hospitalization for diabetic foot infections in a Caribbean nation.
    Cawich SO; Islam S; Hariharan S; Harnarayan P; Budhooram S; Ramsewak S; Naraynsingh V
    Perm J; 2014; 18(1):e101-4. PubMed ID: 24626079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term contemporary outcomes for staged versus primary lower limb amputation in diabetic foot disease.
    Cheun TJ; Jayakumar L; Sideman MJ; Ferrer L; Mitromaras C; Miserlis D; Davies MG
    J Vasc Surg; 2020 Aug; 72(2):658-666.e2. PubMed ID: 31901363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru.
    Cárdenas MK; Mirelman AJ; Galvin CJ; Lazo-Porras M; Pinto M; Miranda JJ; Gilman RH
    BMC Health Serv Res; 2015 Oct; 15():483. PubMed ID: 26503154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The right to bear legs--an amendment to healthcare: how preventing amputations can save billions for the US Health-care System.
    Rogers LC; Lavery LA; Armstrong DG
    J Am Podiatr Med Assoc; 2008; 98(2):166-8. PubMed ID: 18348977
    [No Abstract]   [Full Text] [Related]  

  • 37. Contribution of 30-day readmissions to the increasing costs of care for the diabetic foot.
    Hicks CW; Canner JK; Karagozlu H; Mathioudakis N; Sherman RL; Black JH; Abularrage CJ
    J Vasc Surg; 2019 Oct; 70(4):1263-1270. PubMed ID: 30850287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effective management of recalcitrant diabetic foot ulcers.
    Albert S
    Clin Podiatr Med Surg; 2002 Oct; 19(4):483-91. PubMed ID: 12471856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs of deep foot infections in patients with diabetes mellitus.
    Tennvall GR; Apelqvist J; Eneroth M
    Pharmacoeconomics; 2000 Sep; 18(3):225-38. PubMed ID: 11147390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and economic burden of diabetic foot ulcers: A 5-year longitudinal multi-ethnic cohort study from the tropics.
    Lo ZJ; Surendra NK; Saxena A; Car J
    Int Wound J; 2021 Jun; 18(3):375-386. PubMed ID: 33497545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.